Chen J et al. have reported that Gankyrin expedites the proliferation of ovarian cancer cells driven by follicle-stimulating hormone via the PI3K/AKT/HIF-1α/cyclin D1 pathway activation [36]. Here, PIK3CG is linked to ovarian carcinoma.